Patent · US Active

Blue light photobiomodulation

US12186221B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 12, 2020
Grant dateJan 7, 2025
Priority date
Expiry dateFeb 25, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06T2207/30052
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The invention is directed to a light source device comprising a light emitting element for emitting a blue light having a wavelength ranging from 435 to 500 nm, the light source device being configured to provide the blue light to at least one cell at a transmitted fluence ranging from 0.01 to 18. J/cm2 to promote or induce growth and proliferation of the cell and wherein the light emitting element has a power density ranging from 0.05 to 30 mW/cm2. The invention is also directed to a light source assembly comprising a product adapted to be in contact with the skin or a wound and a light source device connected to the product for providing blue light to at least one skin cell, preferably of the wound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.